This newslink doesn't exist or it was removed.
Go to Homempage.
ABC7 USA Health October 24, 2023
is reviewing an application for the nasal spray vaccine FluMist to be able to be self-administered at home, drugmaker AstraZeneca said Tuesday.The vaccine, the only nasal spray option against flu, has been on the market in the United States since 2003. AstraZeneca has asked the... + más
When is the best time to get a flu shot? And what kind should I get? | Los Angeles Times
Flu shot myths make us sick — experts bust 6 of the major ones | New York Post
The Boston Globe USA Business June 14, 2023
ENERGYAstraZeneca signs deal with Waltham-based firm for renewable natural gasVanguard Renewables has signed a contract with drug giant AstraZeneca to deliver renewable natural gas to all of AstraZeneca’s 12 sites in the United States. Waltham-based Vanguard is developing... + más
High school scores and top performers from Friday, March 24 | Orlando Sentinel
High school scores and top performers from Thursday, March 9 | Orlando Sentinel
ABC News USA Health November 23, 2022
WASHINGTON -- U.S. regulators on Tuesday approved the first gene therapy for hemophilia, a $3.5 million one-time treatment for the blood-clotting disorder.The Food and Drug Administration cleared Hemgenix, an IV treatment for adults with hemophilia B, the less common form of the... + más
FDA approves most expensive drug ever, $3.5 million-per-dose gene therapy for hemophilia B | CBS News
$3.5M gene therapy for hemophilia gets FDA approval | WPLG Local 10
CBS News USA Health November 23, 2022
Washington — U.S. health regulators on Tuesday approved the first gene therapy for hemophilia, a $3.5 million one-time treatment for the blood-clotting disorder. The Food and Drug Administration cleared Hemgenix, an IV treatment for adults with hemophilia B, the less common... + más
$3.5M gene therapy for hemophilia gets FDA approval | ABC News
WPLG Local 10 USA Health November 23, 2022
WASHINGTON – U.S. health regulators on Tuesday approved the first gene therapy for hemophilia, a $3.5 million one-time treatment for the blood-clotting disorder.The Food and Drug Administration cleared Hemgenix, an IV treatment for adults with hemophilia B, the less common... + más
About iurex | Privacy Policy | Disclaimer |